Oct 19, 2017 Last Updated 10:30 AM, Oct 17, 2017

San Raffaele il primo studio clinico per il trattamento della sclerosi multipla con infusione di cellule staminali neurali

Published in Head news
Read 133 times
Rate this item
(0 votes)

Per la prima volta al mondo un paziente affetto da sclerosi multipla cronica in stadio avanzato ha ricevuto una terapia a base di cellule staminali neurali presso l’unità operativa di Neurologia dell’IRCCS Ospedale San Raffaele di Milano. 

Last modified on Monday, 16 October 2017 11:18
Login to post comments

Registered area

Thanks to the support of
merck serono biogen sanofi

Conferences & Courses

XXVII AINI Congress

May 7-10, 2018 
Trieste

 

Workshop Sclerosi Multipla: dall'immunologia all'innovazione …

December 15-16, 2017 
Modena (Baggiovara) - UNA Hotel Modena


Scientific Program

Nature Conferences REGENERATION

November 16-18, 2017
Aula Caravella Santa Maria, San Raffaele Congress Centre, Milan, Itlay

Go to the
...

2nd Americas Schools of Neuroimmunology (ASNI)

October 3-6, 2017
Charlottesville (VA) - USA 

Go to the website

JNIInternational Brain Research Organization
Bringing Neuroscience to the World
JNIJournal of Neuroimmunology
Studies on all branches of neurosciences covering both research and clinical problems of neuroscientific interest.

This website or its third party tools use cookies, which are necessary to its functioning and required to achieve the purposes illustrated in the cookie policy. If you want to know more or withdraw your consent to all or some of the cookies, please refer to the cookie policy. By closing this banner, scrolling this page, clicking a link or continuing to browse otherwise, you agree to the use of cookies. To find out more about the cookies we use and how to delete them, see our Cookie Policy